LAMP3 and melanoma: In the present study we examined the prevalence of several immune cell types: OX40+ activated T lymphocytes, FOXP3+ regulatory T cells, DC-LAMP+ mature DCs and CD123+ plasmacytoid DCs in sentinel lymph nodes of melanoma patients.